Article info
Multiple sclerosis
Original research
Comparing ocrelizumab to interferon/glatiramer acetate in people with multiple sclerosis over age 60
- Correspondence to Dr Anneke van der Walt; anneke.vanderwalt{at}monash.edu
Citation
Comparing ocrelizumab to interferon/glatiramer acetate in people with multiple sclerosis over age 60
Publication history
- Received October 27, 2023
- Accepted February 11, 2024
- First published March 7, 2024.
Online issue publication
July 15, 2024
Article Versions
- Previous version (7 March 2024).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ.